4-(chloromethyl)-3-(4-chlorophenyl)-1-phenyl-1H-pyrazole, 100mg

N-Methyl-1-(4-nitrophenyl)methanamine, 97.0%, 1g

bScope BS.1153-PLPHi para contraste de fases. Triocular con oculares HWF 10x/20 mm y revólver quíntuple E-plan Phase IOS 10/20/S40 S100x

Phenyl trans-styryl sulfone, 95.0%, 5g

6-Bromoimidazo[1,2-a]pyrimidine-2-carboxylic acid, 97%, 1g

Furan-3-sulfonyl chloride, 95.0%, 5g

2-Amino-1-(1-methyl-1 H -imidazol-2-yl)-ethanoldihydrochloride, 95.0%, 250mg

5-(tert-Butyl)-2-hydroxybenzoic acid, 95.0%, 1g

5,11-Dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-11-methyl-5-(2,2,2-trifluoroethyl)-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one, 98%, 25mg

Diphenyl phenylphosphonate, 98% GC, 25g

3-OXO-4-ANDROSTENE-17�-CARBOXYLIc acid, 98.0%, 25g

((Benzyloxy)carbonyl)-L-phenylalanyl-L-phenylalanine, 97%, 200mg

(E)-6-(4-methoxyphenyl)hex-5-en-1-ol, 95%, 500mg